Rare Blood Disorder Drug Gains a Boxed Warning Regulators Overruled the Language Its Maker Proposed

Adzynma’s US label now carries a boxed warning on neutralizing antibodies linked to deaths, added after an FDA order that Takeda contested.

Have A Referral?